# Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

> **NCT01068652** · PHASE4 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 403 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin aspart
- **DRUG:** biphasic insulin aspart 30
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT01068652
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068652, "Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01068652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*